The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| aTyr Pharma Inc | COM | 002120202 | 7,484 | 1,398,889 | SH | SOLE | 1,398,889 | 0 | 0 | ||
| Aadi Bioscience Inc | COM | 00032Q104 | 25,954 | 1,529,402 | SH | SOLE | 1,529,402 | 0 | 0 | ||
| Aclaris Therapeutics Inc | COM | 00461U105 | 78,683 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | ||
| Aerovate Therapeutics Inc | COM | 008064107 | 2,769 | 151,037 | SH | SOLE | 151,037 | 0 | 0 | ||
| Affimed NV | COM | N01045108 | 6,243 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | ||
| Altimmune Inc | COM | 02155H200 | 4,627 | 759,719 | SH | SOLE | 759,719 | 0 | 0 | ||
| Astria Therapeutics Inc | COM | 04635X102 | 3,617 | 538,999 | SH | SOLE | 538,999 | 0 | 0 | ||
| Athira Pharma Inc | COM | 04746L104 | 13,500 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Celldex Therapeutics Inc | COM | 15117B202 | 29,466 | 865,116 | SH | SOLE | 865,116 | 0 | 0 | ||
| Centessa Pharmaceuticals PLC | SPONS ADR | 152309100 | 3,690 | 411,361 | SH | SOLE | 411,361 | 0 | 0 | ||
| Chinook Therapeutics Inc | COM | 16961L106 | 21,003 | 1,283,821 | SH | SOLE | 1,283,821 | 0 | 0 | ||
| Cogent Biosciences Inc | COM | 19240Q201 | 8,155 | 1,088,817 | SH | SOLE | 1,088,817 | 0 | 0 | ||
| Eiger BioPharmaceuticals Inc | COM | 28249U105 | 12,199 | 1,469,767 | SH | SOLE | 1,469,767 | 0 | 0 | ||
| GH Research PLC | ORD SH | G3855L106 | 37,514 | 2,051,060 | SH | SOLE | 2,051,060 | 0 | 0 | ||
| Graphite Bio Inc | COM | 38870X104 | 8,224 | 1,612,617 | SH | SOLE | 1,612,617 | 0 | 0 | ||
| Instil Bio Inc | COM | 45783C101 | 73,800 | 6,865,076 | SH | SOLE | 6,865,076 | 0 | 0 | ||
| LianBio | SPONS ADR | 53000N108 | 19,954 | 5,378,341 | SH | SOLE | 5,378,341 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q200 | 29,516 | 3,156,803 | SH | SOLE | 3,156,803 | 0 | 0 | ||
| Nuvalent Inc | COM | 670703107 | 11,167 | 803,951 | SH | SOLE | 803,951 | 0 | 0 | ||
| Provention Bio Inc | COM | 74374N102 | 8,189 | 1,118,653 | SH | SOLE | 1,118,653 | 0 | 0 | ||
| Relmada Therapeutics Inc | COM | 75955J402 | 61,269 | 2,270,072 | SH | SOLE | 2,270,072 | 0 | 0 | ||
| Savara Inc | COM | 805111101 | 2,496 | 1,905,265 | SH | SOLE | 1,905,265 | 0 | 0 | ||
| Sierra Oncology Inc | COM | 82640U404 | 5,207 | 162,479 | SH | SOLE | 162,479 | 0 | 0 | ||
| Travere Therapeutics Inc | COM | 89422G107 | 51,411 | 1,994,997 | SH | SOLE | 1,994,997 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 36,948 | 4,494,851 | SH | SOLE | 4,494,851 | 0 | 0 | ||
| Viridian Therapeutics Inc | COM | 92790C104 | 34,260 | 1,852,919 | SH | SOLE | 1,852,919 | 0 | 0 | ||
| VistaGen Therapeutics Inc | COM | 92840H202 | 19,899 | 16,047,286 | SH | SOLE | 16,047,286 | 0 | 0 | ||